Full Name
Seng Gee Lim
Variants
Lee Lim, S.G.
Lim, S.G.
Seng, Foreword Gee Lim
Seng, G.L.
Lim Seng Gee
Lim, Seng Gee
Lim, S.-G.
 
Main Affiliation
 
 
Email
mdclimsg@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2010 TO 2019]
Type:  Article

Results 1-12 of 12 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
12010A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis BTan, A.T.; Koh, S.; Goh, W.; Gehring, A.J.; Bertoletti, A. ; Lim, S.G. ; Zhe, H.Y.
21-Oct-2017Acute-on-chronic liver failure in a multi-ethnic Asian city: A comparison of patients identified by Asia-Pacific Association for the Study of the Liver and European Association for the Study of the Liver definitionsRajoo, AS; Lim, SG ; Phyo, WW ; Tun, T; Dan, YY ; Lee, YM ; Low, HC ; Lim, K; Tan, PS; Lee, GH 
3Apr-2012APASL consensus statements and management algorithms for hepatitis C virus infectionOmata, M.; Kanda, T.; Yu, M.-L.; Yokosuka, O.; Lim, S.-G. ; Jafri, W.; Tateishi, R.; Hamid, S.S.; Chuang, W.-L.; Chutaputti, A.; Wei, L.; Sollano, J.; Sarin, S.K.; Kao, J.-H.; McCaughan, G.W.
42010C/EBPα Is Up-Regulated in a Subset of Hepatocellular Carcinomas and Plays a Role in Cell Growth and ProliferationLu, G. ; Leung, C.H. ; Tan, C.M.-Y.; Low, S.Y.; Hooi, S.C. ; Yan, B.; Salto-Tellez, M. ; Aung, M.O.; Lim, S.G. 
5Feb-2013Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapyCheng, Y. ; Guindon, S.; Rodrigo, A.; Lim, S.G. 
62011Open-label Phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patientsPatel, K.; Lim, S.G. ; Cheng, C.W.; Lawitz, E.; Tillmann, H.L.; Chopra, N.; Altmeyer, R.; Randle, J.C.R.; McHutchison, J.G.
713-Jul-2010PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 PhosphataseWang, Haihe; Vardy, Leah A; Tan, Cheng Peow; Loo, Jia Min; Guo, Ke; Li, Jie; Lim, Seng Gee ; Zhou, Jianbiao ; Chng, Wee Joo ; Ng, Siok Bian ; Li, Hui Xiang; Zeng, Qi
8Jan-2014Reduction of HBV replication prolongs the early immunological response to IFNα therapyTan, A.T.; Hoang, L.T.; Chin, D.; Rasmussen, E.; Lopatin, U.; Hart, S.; Bitter, H.; Chu, T.; Gruenbaum, L.; Ravindran, P.; Zhong, H.; Gane, E.; Lim, S.G. ; Chow, W.C.; Chen, P.-J.; Petric, R.; Bertoletti, A. ; Hibberd, M.L.
92010Reliability and validity of a Chinese version's health-related quality of life questionnaire for hepatitis B patientsOng, S.C.; Lim, S.G. ; Li, S.C. 
10Sep-2011Risk factors for mortality in cirrhotic patients with sepsisLim, L.-G.; Tan, X.-X.E.; Woo, S.-J.; Dan, Y.-Y. ; Lee, Y.-M.; Lai, V.; Lim, S.-G. 
111-Jan-2019Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infectionLow, EXS; Tripon, E; Lim, K0; Tan, PS ; Low, HC ; Dan, YY ; Lee, YM ; Muthiah, M ; Loo, WM ; Koh, CJ ; Phyo, WW ; Pang, JX; Lim, SG ; Lee, GH 
122015Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyMarcellin Patrick; Wursthorn Karsten; Wedemeyer Heiner; Chuang Wan Long; Lau George; Avila Claudio; Peng Cheng Yuan; Gane Edward; Lim Seng Gee ; Fainboim Hugo; Foster Graham R.; Safadi Rifaat; Rizzetto Mario; Manns Michael; Bao Webin; Trylesinski Aldo; Naoumov Nikolai